FR2372816A1 - N-Aminoalkyl-1,2-benzisothiazol-3-one derivs. - useful as thrombocyte aggregation inhibitors for humans and animals - Google Patents

N-Aminoalkyl-1,2-benzisothiazol-3-one derivs. - useful as thrombocyte aggregation inhibitors for humans and animals

Info

Publication number
FR2372816A1
FR2372816A1 FR7736523A FR7736523A FR2372816A1 FR 2372816 A1 FR2372816 A1 FR 2372816A1 FR 7736523 A FR7736523 A FR 7736523A FR 7736523 A FR7736523 A FR 7736523A FR 2372816 A1 FR2372816 A1 FR 2372816A1
Authority
FR
France
Prior art keywords
aryl
humans
alkyl
animals
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7736523A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robapharm AG
Original Assignee
Robapharm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robapharm AG filed Critical Robapharm AG
Publication of FR2372816A1 publication Critical patent/FR2372816A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Benzisotheriazolones of formula (I) and their acid addn. salts when a basic N is present, are new. In the formula R1 and R2 are H, halo, 1-6C alkyl alkoxy, haloalkyl or alkanoylamino, NO2 or NH2 or together on adjacent C they are 3-6C alkylene or 1-3C oxyalkyleneoxy. X is 1-12C opt. branched alkylene, R3=H 1-6C alkyl, (opt. substD. by aryl or OH), 2-6C alkenyl, aryl or N-heterocyclyl, R4=1-6C alkyl (opt. substd. by aryl or OH), 2-6C alkenyl or aryl, or if R3 is not = H, also N-heterocyclyl. R3 and R4 are not both H or lower alkyl when R1 and R2 at positions 5 and 7 are H or halo, and X is lower alkylene. They are prepd. e.g. by reacting the corresp. N-H cpd. with Q.X.NR3R4(Q=easily eliminated gp. (I) are thrombocyte aggregation inhibitors so are useful for preventing or treating thrombosis in humans or animals. The pref. dose for adult humans is 10-500 mg orally 1-3 times per day. (I) can also be used to conserve blood in vitro, pref. at 0.01-50 mu g/ml.
FR7736523A 1976-12-04 1977-12-05 N-Aminoalkyl-1,2-benzisothiazol-3-one derivs. - useful as thrombocyte aggregation inhibitors for humans and animals Withdrawn FR2372816A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5064676 1976-12-04

Publications (1)

Publication Number Publication Date
FR2372816A1 true FR2372816A1 (en) 1978-06-30

Family

ID=10456767

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736523A Withdrawn FR2372816A1 (en) 1976-12-04 1977-12-05 N-Aminoalkyl-1,2-benzisothiazol-3-one derivs. - useful as thrombocyte aggregation inhibitors for humans and animals

Country Status (12)

Country Link
JP (1) JPS5384969A (en)
AR (1) AR216841A1 (en)
BE (1) BE861326A (en)
DE (1) DE2753391A1 (en)
DK (1) DK539577A (en)
ES (1) ES464729A1 (en)
FR (1) FR2372816A1 (en)
NL (1) NL7713355A (en)
PL (1) PL202595A1 (en)
PT (1) PT67348B (en)
SE (1) SE7713711L (en)
ZA (1) ZA776857B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860750D1 (en) * 1977-06-20 1981-09-17 Beecham Group Plc Antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions
JPS58177915A (en) * 1982-04-12 1983-10-18 Green Cross Corp:The Antithrombotic agent
GB9626570D0 (en) * 1996-12-20 1997-02-05 Zeneca Ltd Process for making benzisothiazolin-3-ones

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227715A (en) * 1961-07-25 1966-01-04 Knoll Ag Benzisothiazolones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227715A (en) * 1961-07-25 1966-01-04 Knoll Ag Benzisothiazolones

Also Published As

Publication number Publication date
ES464729A1 (en) 1978-09-01
SE7713711L (en) 1978-06-05
ZA776857B (en) 1978-09-27
JPS5384969A (en) 1978-07-26
BE861326A (en) 1978-05-29
DE2753391A1 (en) 1978-06-08
PT67348A (en) 1977-12-01
NL7713355A (en) 1978-06-06
PL202595A1 (en) 1978-10-09
PT67348B (en) 1979-04-26
AR216841A1 (en) 1980-01-31
DK539577A (en) 1978-06-05

Similar Documents

Publication Publication Date Title
OA09334A (en) "Amino Acid Derivatives".
ES2006142A6 (en) Quinolinecarboxylic acid derivatives.
ES2071725T3 (en) DIESTER ASCORBIC ACID AND TOCOPHERIL PHOSPHATE FOR THE INHIBITION OF THE MAILLARD REACTION.
HK78193A (en) Preparations for the treatment of mycoplasmoses and bacterial infections in poultry
KR900700467A (en) Macrocyclic chelating agents and their chelating agents
FI911286A0 (en) CHEMICAL FOERENINGAR.
ATE88700T1 (en) CONDENSED PYRAZOLE-3-OXO-PROPANNITRILE DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
FR2372816A1 (en) N-Aminoalkyl-1,2-benzisothiazol-3-one derivs. - useful as thrombocyte aggregation inhibitors for humans and animals
DK624989D0 (en) UNKNOWN RELATIONSHIPS
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
ATE140452T1 (en) NEW IMIDAZOLE COMPOUNDS, PROCESSES FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS BASED ON THESE COMPOUNDS AND SOME INTERMEDIATE PRODUCTS
MY102275A (en) Antimykotische aminoazole ii
ES8300709A1 (en) Heterocyclic compounds, compositions thereof, their preparation and use.
FR2267102A1 (en) 2,6-Di(branched alkylamino)pyridines - for treatment of fatty degeneration and diabetes
ES8104285A1 (en) Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions.
FR2363560A1 (en) NEW COMPOUND WITH ANALGESIC ACTION AND THERAPEUTIC COMPOSITIONS IN CONTAINER
GB1530166A (en) Adenine derivatives
ES8800930A1 (en) New oxo-diazine cpds.
ATE30592T1 (en) PENICILLIN DERIVATIVES.
ES2041649T3 (en) ANTIBACTERIAL MEDICINES FOR FISH.
BE759304Q (en) Phenoxyalkylamines coronary vasodilators and
FR2381041A1 (en) Antiulcer hydroxy-substd. di:carboxylic acid derivs. - prepd. e.g. by redn. of hydroxy-iso-canadenoic acid (BE 16.8.78)
ATE6514T1 (en) CLAVULAN ACID DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS.

Legal Events

Date Code Title Description
ST Notification of lapse